UGT2B7
UGT2B7 (UDP glucuronosyltransferase family 2 member B7, also known as UGT2B9) is an endoplasmic reticulum enzyme that conjugates lipophilic substrates with glucuronic acid. This phase II reaction increases water solubility and supports the elimination of drugs, xenobiotics and endogenous compounds. Browse Assay Genie's current range of UGT2B7 research reagents below, or read on for the biology behind the target.
UGT2B7 is a UDP-glucuronosyltransferase that catalyses phase II biotransformation reactions. Lipophilic substrates are conjugated with glucuronic acid, which raises the water solubility of the metabolite and allows excretion into urine or bile. The enzyme is essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds.
Among endogenous substrates, UGT2B7 glucuronidates steroid hormones, including the androgens epitestosterone and androsterone and the oestrogens estradiol, epiestradiol, estriol and catechol oestrogens. NCBI Gene notes a specificity for 3,4-catechol oestrogens and estriol, suggesting a role in regulating the level and activity of these potent oestrogen metabolites. The enzyme also regulates retinoic acid, a vitamin A metabolite involved in apoptosis, cellular growth and differentiation, and embryonic development. It contributes to bile acid detoxification, and it glucuronidates arachidonic acid and derived eicosanoids such as 15-HETE, 20-HETE, PGE2, PGB1 and F2-isoprostanes, as well as the phytochemical ferulic acid.
UGT2B7 also acts on therapeutic drugs. These include the angiotensin receptor antagonists losartan, caderastan and zolarsatan, which act against AGTR1, and the immunosuppressant mycophenolate. The protein belongs to the UDP-glycosyltransferase family and sits in the HGNC group of UDP glucuronosyltransferases. It is localised to the endoplasmic reticulum (microsome) membrane, and alternative splicing of the UGT2B7 gene gives multiple transcript variants. The previous HGNC name was UDP glycosyltransferase 2 family, polypeptide B7. A rat ortholog, Ugt2b7, is recorded.
UGT2B7 glucuronidates drugs such as losartan and mycophenolate, making it relevant to studies of drug biotransformation, detoxification and elimination.
The enzyme conjugates androgens and oestrogens, including catechol oestrogens and estriol, so it is studied in regulating active steroid metabolite levels.
UGT2B7 regulates retinoic acid levels, linking glucuronidation to apoptosis, cell growth, differentiation and embryonic development.
Glucuronidation of bile acids, arachidonic acid and eicosanoids such as PGE2 and 20-HETE makes UGT2B7 a subject in lipid metabolism research.
UGT2B7 catalyses the transfer of glucuronic acid to lipophilic substrates, increasing their water solubility so they can be excreted in urine or bile. Its substrates include drugs, steroid hormones, bile acids, retinoic acid and arachidonic acid-derived eicosanoids.
Yes. UGT2B9 is listed as an alias, and the HGNC full name is UDP glucuronosyltransferase family 2 member B7. The previous name was UDP glycosyltransferase 2 family, polypeptide B7. UniProt calls the protein UDP-glucuronosyltransferase 2B7, and alternative splicing gives multiple transcript variants.
A rat ortholog, Ugt2b7, is recorded for the human gene; no mouse ortholog is listed in the data used here. UGT2B7 belongs to the wider UDP-glycosyltransferase family. Check the datasheet of any product for its validated reactivity.
Other UDP-glycosyltransferase family members with research products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P16662; product specifications from Assay Genie datasheets.